Compounds > rubidium
Page last updated: 2024-08-26

rubidium and xe 991, anthracenone

rubidium has been researched along with xe 991, anthracenone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crankshaw, DJ; Scott, CW; Trivedi, S; Wilkins, DE1
Chatelain, P; Fuks, B; Gillard, M; Wolff, C1
Dunlop, J; Jow, F; Kowal, D; Maddox, T; Mekonnen, B; Shen, R; Tseng, E; Wang, K1

Other Studies

3 other study(ies) available for rubidium and xe 991, anthracenone

ArticleYear
A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.
    Analytical biochemistry, 2003, Aug-15, Volume: 319, Issue:2

    Topics: Anthracenes; Carbamates; Cell Line; Clone Cells; Dose-Response Relationship, Drug; Humans; Indoles; KCNQ2 Potassium Channel; Kinetics; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Pyridines; Quaternary Ammonium Compounds; Rubidium; Spectrophotometry, Atomic; Tetraethylammonium; Transfection

2003
[3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.
    European journal of pharmacology, 2005, Jul-25, Volume: 518, Issue:1

    Topics: Animals; Anthracenes; Binding, Competitive; Brain; Cell Membrane; Chlorides; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Indoles; KCNQ3 Potassium Channel; Ketoconazole; Kinetics; Liver; Male; Miconazole; Potassium Channels, Voltage-Gated; Pyridines; Pyrilamine; Quinidine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rubidium; Tritium

2005
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
    Assay and drug development technologies, 2006, Volume: 4, Issue:4

    Topics: Animals; Anthracenes; Benzodiazepines; CHO Cells; Chromans; Cricetinae; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; KCNQ1 Potassium Channel; Long QT Syndrome; Membrane Potentials; Myocardium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Rats; Reproducibility of Results; Risk Factors; Rubidium; Spectrophotometry, Atomic; Tetraethylammonium

2006